ARI

CUBE acquires Reg-Room to further extend its regulatory intelligence and horizon scanning capabilities

Retrieved on: 
木曜日, 5月 9, 2024
Hg, AI, Insurance, Partnership, ARI, Automation, RCM, Acquisition

LONDON, May 9, 2024 /PRNewswire/ -- CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), announces today its acquisition of Reg-Room, LLC ("Reg-Room"), a leading regulatory intelligence provider serving the financial services industry.

Key Points: 
  • LONDON, May 9, 2024 /PRNewswire/ -- CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), announces today its acquisition of Reg-Room, LLC ("Reg-Room"), a leading regulatory intelligence provider serving the financial services industry.
  • Nick Paraskeva, founder of Reg-Room, said, "We're excited to join the CUBE team and bring our regulatory expertise to an even broader audience.
  • Our mission has always been to provide our customers with the tools they need to navigate the complexities of regulatory compliance.
  • We are incredibly excited about the opportunities this presents in delivering transformative regulatory capabilities to customers worldwide."

Krach Institute for Tech Diplomacy at Purdue Unveils World’s First Tech Diplomacy Academy, Pioneering a New Era of Global Leadership

Retrieved on: 
火曜日, 4月 30, 2024
Education, Technology, White House, Federal Government, State, Local, Security, Training, Other Defense, Defense, Internet, Public Policy, Government, Continuing, Science, Partnership, ARI, Public diplomacy, Veritas Capital, German Marshall Fund, Purdue University, Knowledge, Diplomacy, Semiconductor, The German, United, Assistant, NYCU, Civilization, Security Commission, Computer science and engineering, The Business Council, Comprehension, National Chengchi University, Artificial intelligence, Freedom, Engineering, Australian Strategic Policy Institute, Multimedia, Child, Lead, Tech, Hoover Institution, Policy, Authoritarianism, University, Curriculum, STEM, Krach, NCCU, Commissioner, ASPI, Quad, Renewable energy

Pioneered by the Krach Institute, Tech Diplomacy is a groundbreaking category that integrates technology, commercial and foreign policy expertise to guide the trajectory of trusted tech toward advancing freedom, security and prosperity worldwide.

Key Points: 
  • Pioneered by the Krach Institute, Tech Diplomacy is a groundbreaking category that integrates technology, commercial and foreign policy expertise to guide the trajectory of trusted tech toward advancing freedom, security and prosperity worldwide.
  • View the full release here: https://www.businesswire.com/news/home/20240430522409/en/
    Krach Institute launches Tech Diplomacy Academy (Graphic: Business Wire)
    “Technology shapes every facet of our personal and professional lives, and the destiny of nations,” said Keith Krach, former Under Secretary of State, and Co-founder and Chairman of the Krach Institute for Tech Diplomacy at Purdue.
  • “With the launch of the Tech Diplomacy Academy, we are not merely responding to this reality; we are shaping it.
  • To join the Tech Diplomacy Academy and see what others are saying, please visit TechDiplomacyAcademy.org .

Palantir Designated “Awardable” Vendor for Department of Defense Chief Digital and Artificial Intelligence Office’s Tradewinds Solutions Marketplace

Retrieved on: 
水曜日, 4月 17, 2024
Software, Other Defense, Professional Services, Contracts, Technology, White House, Federal Government, Defense, Artificial Intelligence, Data Analytics, Transport, Military, Public Policy, Government, Logistics, Supply Chain Management, Congress, Trade winds, Government agency, AI, ARI, Artificial intelligence, Artificiality, Digital, PLTR, Acquisition, AIP, Fortune 500, Marketplace, Sales

Palantir Technologies Inc. (NYSE: PLTR) today announced that it has been designated as an “Awardable” vendor for the Chief Digital and Artificial Intelligence Office’s (CDAO) Tradewinds Solutions Marketplace.

Key Points: 
  • Palantir Technologies Inc. (NYSE: PLTR) today announced that it has been designated as an “Awardable” vendor for the Chief Digital and Artificial Intelligence Office’s (CDAO) Tradewinds Solutions Marketplace.
  • The Tradewinds Solutions Marketplace is a digital repository of post-competition, readily awardable capabilities that address the DoD’s most significant challenges in the Artificial Intelligence/Machine Learning (AI/ML), data, and analytics space.
  • Palantir was recognized among a competitive field of applicants to the Tradewinds Solutions Marketplace whose solutions demonstrated innovation, scalability, and potential impact on DoD missions.
  • Government customers interested in viewing the solution can create a Tradewinds Solutions Marketplace account at tradewindAI.com.

New AMCP Research Institute Expands Managed Care Pharmacy Research Opportunities

Retrieved on: 
月曜日, 4月 15, 2024
Health, Other Science, Managed Care, Research, Science, Pharmaceutical, Biotechnology, Public, Safety, MHL, ARI, Doctor of Philosophy, Pharmacist, CAE, Patient, Doctor of Pharmacy, AMCP, Management

The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI) , a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy.

Key Points: 
  • The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI) , a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy.
  • Incorporating AMCP’s existing Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), the ARI will expand the scope of research opportunities for AMCP, thereby helping to advance the larger goal of improving public health in the United States.
  • “The ARI will allow us to be more comprehensive in our efforts.”
    Across AMCP membership, there is increasing interest in practical research that advances the cause of managed care pharmacy and helps to improve public health.
  • The ARI will be an expanded and rigorous resource to support AMCP’s research needs and overall mission.

Apollo Commercial Real Estate Finance, Inc. Announces Dates for First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
月曜日, 4月 8, 2024
ARI, Webcast

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2024 financial results on Tuesday, April 30, 2024 at 10:00 a.m. Eastern Time.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its first quarter 2024 financial results on Tuesday, April 30, 2024 at 10:00 a.m. Eastern Time.
  • The Company’s first quarter 2024 financial results will be released after the market closes on Monday, April 29, 2024.
  • During the conference call, Company officers will review first quarter 2024 performance, discuss recent events and conduct a question-and-answer period.
  • The Company will also post a link in the Stockholders’ section on ARI’s website for a live webcast.

Surge Copper Announces C$3.8 Million Strategic Investment by African Rainbow Minerals Limited

Retrieved on: 
火曜日, 4月 2, 2024
Copper, IRA, National Instrument 43-101, TSX Venture Exchange, SURG, South African Reserve Bank, News, ARM, Acquisition, National instrument, TSX, Concurrency, Strategy, ARI, Qualified person (European Union), Security (finance)

Vancouver, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG ) (OTCQB: SRGXF ) (Frankfurt: G6D2 ) (“Surge” or the “Company”) is pleased to announce that it has entered into a subscription agreement for a private placement financing (the “Strategic Placement”) with a new cornerstone strategic investor, African Rainbow Minerals Limited (JSE: ARI) (“ARM”).

Key Points: 
  • Vancouver, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG ) (OTCQB: SRGXF ) (Frankfurt: G6D2 ) (“Surge” or the “Company”) is pleased to announce that it has entered into a subscription agreement for a private placement financing (the “Strategic Placement”) with a new cornerstone strategic investor, African Rainbow Minerals Limited (JSE: ARI) (“ARM”).
  • Under the terms of the Strategic Placement, ARM, through its wholly-owned subsidiary ARM Copper Company Proprietary Limited (“ARM Copper”), will subscribe for 39,608,708 common shares (the “Strategic Placement Common Shares”) of Surge at C$0.095 per Strategic Placement Common Share, representing an approximately 18% premium to the 20-day volume weighted average price of the Company’s common shares on the TSX Venture Exchange as at April 1, 2024, for gross proceeds of approximately C$3,762,827.
  • Upon completion of the Strategic Placement, ARM (through ARM Copper) will own 15.0% of Surge’s issued and outstanding common shares on a non-diluted basis.
  • Leif Nilsson, Chief Executive Officer, commented: “We are excited to be welcoming ARM as a strategic investor into Surge.

HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4

Retrieved on: 
火曜日, 4月 2, 2024
Commitment, Growth, IBN, CFO, Physician, Patient, Lead, Sale, Way, Retirement, ARI, OTCQB, Core, Health, Pharmaceutical industry

With strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.

Key Points: 
  • With strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.
  • Dramatic Net Loss Reduction: A significant decrease in net loss to $1.01 million in 2023 from $8.82 million in 2022 illustrates the positive impact of our strategic divestitures, operational efficiencies, and profit stabilization despite temporary staffing changes.
  • Strategic Initiatives Lead to Reduced Operating Loss: A 73% reduction in operating loss to $1.11 million in Q4 2023, demonstrating our resilience and strategic focus during a period of staffing transition.
  • George O'Leary, CFO of HealthLynked, added, "Our strategic decisions throughout 2023 have laid a solid groundwork for growth.

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

Retrieved on: 
火曜日, 4月 2, 2024
Patient, MIB, ARI, Therapy, AAO, Research, Surgeon, Thomas Jefferson University, German Research Foundation, Chairperson, American Diabetes Association, Macular degeneration, SAB, FACS, Food, Cornell University, Empire, University, Castle Connolly Medical, Laborie (company), Publication, Emerita, AMD, FDA, Cochrane (organisation), Moorfields Eye Hospital, American Academy, Most, Consultant, Physician, Royal college, Diabetic retinopathy, Commander, Pharmaceutical industry

WATERTOWN, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. These three world-renowned retinal specialists will support advancement of the Company’s global clinical strategy ahead of the anticipated initiation of its Phase 3 pivotal trials in wet age-related macular degeneration (wet AMD) in the second half of this year. Additionally, the Company announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, DURAVYUTM (vorolanib intravitreal insert) for the Company’s lead product candidate, EYP-1901.

Key Points: 
  • “The SAB’s strategic counsel, global expertise, and scientific knowledge will be incredibly valuable during this critical time in EyePoint’s growth and expansion.
  • Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad.
  • FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University.
  • He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA.

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

Retrieved on: 
木曜日, 3月 28, 2024
Galactitol, MAA, New Drug Application, Patient, Ageing, NDA, PRV, EMA, Doctor of Philosophy, Marketing, Priority review, Therapy, ARI, Food, FDA, CHMP, PDUFA, Pharmaceutical industry

The FDA has set a new Prescription Drug User Fee Act (PDUFA) target action date of November 28, 2024.

Key Points: 
  • The FDA has set a new Prescription Drug User Fee Act (PDUFA) target action date of November 28, 2024.
  • In February 2024, the Company announced that the FDA accepted and granted Priority Review to the NDA.
  • “While the PDUFA action date extension represents a delay, we remain confident in the potential for govorestat approval for Galactosemia and we will continue to work closely with the FDA throughout the review process,” said Shoshana Shendelman, PhD, Founder and CEO of Applied Therapeutics.
  • If approved, govorestat would be the first medication indicated for the treatment of Galactosemia and would be Applied Therapeutics’ first commercial product.

NEW STUDY FINDS NINE IN TEN CANADIANS SUPPORT A FULLY FUNDED CANADA DISABILITY BENEFIT.

Retrieved on: 
月曜日, 4月 8, 2024
MP, CDB, Disability, Organization, Letter, Angus Reid (entrepreneur), Federation, Partnership, Dignity, Poverty, Food, Parliament, MBM, ARI, Government, NDP, Daily Bread Food Bank, Health insurance

Although results found overwhelming support for the benefit, Canadians are critical of the pace of implementation and do not trust that government will follow through.

Key Points: 
  • Although results found overwhelming support for the benefit, Canadians are critical of the pace of implementation and do not trust that government will follow through.
  • The Canada Disability Benefit has the potential to be one of Canada's most important programs and could lift nearly one million Canadians out of poverty if fully funded."
  • For Canadians concerned about government debt, a fully funded benefit will reduce these downstream costs, all while helping Canadians with disabilities live a life of dignity.
  • Over 200,000 letters have been sent to MPs across the country expressing support for a fully funded Canada Disability Benefit.